arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Aclarion, Inc.

ACON
$2.26 ▼ -0.09 (-3.83%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
22 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Aclarion, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.8M
Dividend Yield
Revenue Growth 11.3%
Op. Margin
ROIC -15.2%
FCF / Share $-1.24
Trailing P/E
Price / Book 0.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

22-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$21.14K
↑ +11.3%
Net Income Profit after all expenses
$-2.85M
↓ -40.1%
FCF / Share Free cash flow per share
$-1.24
↑ +89.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
15
Cash Quality
65

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters